Why the study?
Does hydrochlorothiazide added to nadolol reduce blood pressure in patients with pretreatment diastolic blood pressure between 95 and 109 mm Hg?
Does hydrochlorothiazide added to nadolol reduce blood pressure in patients with pretreatment diastolic blood pressure between 95 and 109 mm Hg?
In patients treated with nadolol, low-dose hydrochlorothiazide (12.5 mg/day) does not significantly reduce blood pressure, suggesting higher doses (50 mg/day) are required for combined efficacy.
Answers are grounded in this paper and cite their sources.
Low-dose hydrochlorothiazide adds no benefit to nadolol; confirms dose-dependent synergy is required for combination antihypertensive efficacy.
In a double-blind crossover study, 13 patients with pretreatment diastolic blood pressure between 95 and 109 mm Hg received nadolol, 80 mg/day, plus placebo of hydrochlorothiazide and nadolol, plus three different doses of active hydrochlorothiazide. Patients remained on each active regimen for 3 weeks, with an intervening placebo period of 2 to 4 weeks. With 12.5 mg of hydrochlorothiazide daily plus nadolol, there was no greater reduction of blood pressure than with nadolol alone. A dose of 25 mg of hydrochlorothiazide was associated with a significantly greater decrease in systolic but not diastolic pressure, as compared with nadolol alone. A significantly greater reduction in both systolic and diastolic blood pressure was obtained only with the 50 mg/day dose of hydrochlorothiazide. Extension to 6 weeks of treatment with 12.5 mg/day failed to lower the blood pressure more than the level seen at 3 weeks. These results suggest that in combination with nadolol, 12.5 mg of hydrochlorothiazide per day has no significant antihypertensive effect. There was no evidence of a flat dose-response curve in the daily dose range of 12.5 to 50 mg. For most patients, a dose of 50 mg of hydrochlorothiazide was required to lower both systolic and diastolic blood pressure significantly below the level obtained with nadolol alone.
No takes yet. Share an insight, caveat, or question.
Magee et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: